CDEK by Data4ThePeople

Sign in Sign up

← All organizations

OSE Immunotherapeutics

For profitWebsite ↗

Also known as: OSE Immunotherapeutics

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jun 30, 2024

Timeline

2010s

Jun 1, 2012
OSE Immunotherapeutics— Founded

Drugs by trial phase (15 distinct, 11 trials)

Phase 3 (3 own, 0 via acquisition)

Phase 2 (9 own, 0 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (12)

NCT06472245Lead sponsorPhase 3Jun 30, 2024
NCT05751798Lead sponsorPhase 1/Phase 2Dec 20, 2022
NCT04713514CollaboratorPhase 2Aug 5, 2021
NCT04837092CollaboratorPhase 1/Phase 2Jun 30, 2021
NCT04885361Lead sponsorPhase 1May 26, 2021
NCT04882007Study directorPhase 2Oct 2, 2020
NCT04882007Lead sponsorPhase 2Oct 2, 2020
NCT03990233Lead sponsorPhase 1Apr 16, 2019
NCT03806309CollaboratorPhase 2Feb 7, 2019
NCT03980080Lead sponsorPhase 1Dec 19, 2018
NCT02654587Lead sponsorPhase 3Feb 1, 2016
NCT02800811Lead sponsorPhase 1Apr 1, 2015

Details

Founded: Nantes, FR Jun 1, 2012
Last known activity: Jun 30, 2024